Skip to content

Microneurography and Intraneural Microstimulation for Upper Limb Sensory Investigation in Healthy and Amputee Subjects

Experimental Study to Investigate Sensory Control of the Upper Limb Through Microneurography and to Restore Near-natural Tactile Sensations Through Intraneural Microstimulation in Healthy and Amputee Subjects

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07691957
Acronym
MICROAMP
Enrollment
100
Registered
2026-07-09
Start date
2024-03-04
Completion date
2026-12-31
Last updated
2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects, Upper Limb Amputation

Keywords

Microneurography, Intraneural Microstimulation, Somatosensory System, Upper limb amputation

Brief summary

The goal of this experimental study is to investigate the somatosensory system through intraneural recording and stimulation of the median nerve in healthy volunteers and participants with upper-limb amputation. The main questions it aims to answer are: * How does median nerve activity encode tactile perception during different types of mechanical tactile stimulation in healthy subjects? * How can tactile information be artificially encoded and restored through intraneural microstimulation in both healthy subjects and upper-limb amputee participants? How rich and functionally meaningful is the restored sensory information? * What are the neurophysiological mechanisms underlying tactile stimulus processing and the associated patterns of brain activation during tactile stimulation? Participants will undergo median nerve recordings using microneurography during controlled mechanical tactile stimulation, as well as intraneural microstimulation with specific patterns to evoke near-natural tactile sensations. They will perform perceptual reporting tasks related to stimulus type, intensity, and localization, as well as psychophysical tests under different stimulation conditions. When possible, they will also undergo non-invasive recordings of brain activity using electroencephalography during sensory stimulation.

Detailed description

Participants will attend the laboratory where the entire research protocol will be conducted in a single visit lasting up to 4 hours. Medical history and a physical examination will be collected. In participants with amputation, additional clinical information from previous neurological assessments will be reviewed (including medical records, nerve conduction velocity data, and ultrasound or MRI examinations required to verify inclusion/exclusion criteria). Psychometric tests will also be administered to assess language abilities, visuospatial skills, and general intelligence, ensuring that participants are able to understand and perform the experimental tasks. If inclusion and exclusion criteria are met, participants will undergo microneurography and/or intraneural microstimulation procedures. Participants will be seated comfortably, with the dominant arm (healthy volunteers) or the residual limb (participants with amputation) supported. A trained medical operator will identify the median nerve using external stimulation and/or ultrasound guidance to assist electrode insertion. The active electrode will be inserted into the nerve, while a reference electrode will be placed in the subcutaneous tissue a few centimeters away. Correct electrode placement will then be refined using intraneural stimulation. Once the nerve fascicle is reached, tactile stimulation of the hand will be used to identify single mechanoreceptive units. Final electrode placement will be confirmed by visual and auditory inspection of the neural signal. The median nerve activity must be clearly distinguishable from background activity when mechanical stimuli are applied to the skin. During electrode insertion, participants will be instructed to remain still until the procedure is completed. The intraneural microstimulation session, performed in both healthy volunteers and participants with upper-limb amputation, is preceded by peripheral neural recordings using microneurography during the presentation of tactile stimuli (e.g., Von Frey filaments). This step is used for accurate nerve localization and preliminary assessment of the receptors and their receptive fields. Once the neural target is identified, participants undergo intraneural stimulation involving the perception and recognition of artificially generated tactile stimuli. These stimuli are delivered via intraneural microstimulation and are derived from mechanoneural transduction, using a sensorized artificial finger interacting with different surfaces to encode surface-dependent tactile information. Participants will be asked to recognize different properties of the presented stimuli. During the tests, electroencephalographic (EEG) activity may be recorded using a 128-channel EEG system, synchronized with the onset of stimulation.

Interventions

Microneurography is a minimally invasive neurophysiological technique that allows direct recording of the electrical activity of single peripheral nerve fibers using specific microelectrodes inserted into the nerve.

PROCEDUREIntraneural Microstimulation

Intraneural microstimulation is a minimally invasive neurophysiological technique in which small electrical currents are delivered through a microelectrode inserted into a peripheral nerve to selectively activate nerve fibers and evoke sensory perceptions.

Sponsors

Azienda Ospedaliero, Universitaria Pisana
Lead SponsorOTHER
Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy participants * Age between 18-60 years, of any sex * Signed informed consent * No neurological diseases * Presence of both intact upper limbs * Normal language, visuospatial, and general intellectual abilities, assessed using the Wechsler Adult Intelligence Scale-Revised (WAIS-R) (Appendix 1) Amputee participants * Age between 18-60 years, of any sex * Signed informed consent * Upper-limb amputation (transradial or hand amputation) * Stable amputation for at least one year * Normal language, visuospatial, and general intellectual abilities, assessed using the Wechsler Adult Intelligence Scale-Revised (WAIS-R) (Appendix 1) * Evidence of residual peripheral nerve function in the stump, based on nerve conduction studies as documented in clinical records

Exclusion criteria

Healthy participants * Conditions affecting perceptual abilities * Inability to provide informed consent * Pregnancy or breastfeeding (self-reported) * Clinical conditions that, in the judgment of the investigator responsible for recruitment, may interfere with microneurography, microstimulation, and EEG procedures * Current or past substance abuse * Brain injury with residual motor impairment * Depression * Presence of neurological or musculoskeletal disorders * Diabetes mellitus * Current or previous dermatological conditions * Morphological nerve abnormalities, as indicated by ultrasound or MRI findings in clinical records * Upper-limb amputation Amputee participants * Psychological and/or cognitive disorders * Inability to provide informed consent * Pregnancy or breastfeeding (self-reported) * Clinical conditions that, in the judgment of the investigator responsible for recruitment, may interfere with microneurography, microstimulation, and EEG procedures * Current or past substance abuse * Brain injury with residual motor impairment * Depression * Presence of neurological or musculoskeletal disorders * Diabetes mellitus * Current or previous dermatological conditions * Morphological nerve abnormalities, as indicated by ultrasound or MRI findings in clinical records * Bilateral upper-limb amputation

Design outcomes

Primary

MeasureTime frameDescription
Mechanoreceptor identification success rateDuring the experimental protocol (up to 3 hours)The proportion of experimental sessions in which a single mechanoreceptive afferent is successfully isolated and identified using MNG during controlled mechanical tactile stimulation, expressed as the percentage of successful recordings (%).
Mechanoreceptor classification accuracyDuring the experimental session (up to 3 hours)The accuracy of mechanoreceptor type classification (e.g., SA1, SA2, RA, PC) based on MNG recordings during mechanical tactile stimulation, expressed as the percentage of correctly classified receptors (%).
Peripheral afferent firing rate during tactile stimulationDuring the experimental session (up to 3 hours)The mean firing rate (spikes/s) of mechanoreceptive afferents recorded by MNG during controlled mechanical tactile stimulation.
Tactile mechanical detection thresholdDuring the experimental session (up to 3 hours)The minimum stimulus intensity (expressed in grams of calibrated Von Frey Hairs) required to evoke a consistent neural response during mechanical tactile stimulation.
Receptive field size of mechanoreceptive afferentsDuring the experimental session (up to 3 hours)The spatial extent of skin area (mm²) eliciting neural responses during mechanical tactile stimulation mapped via MNG.
Perceived sensory perception during intraneural microstimulationDuring the experimental protocol (up to 3 hours)Participant-reported sensory percepts will be classified into predefined categories (e.g., pressure, vibration, tingling, tapping) and summarized as the frequency and percentage of each sensory class across stimulation conditions.
Perceived intensity of tactile sensations elicited during intraneural microstimulationDuring the experimental protocol (up to 3 hours)Participants will rate the perceived intensity of each evoked sensation using a numerical rating scale from 0 (no sensation) to 10 (maximum imaginable intensity). Mean and standard deviation (or median and interquartile range) will be reported for each stimulation condition.
Perceived location of tactile sensations elicited during intraneural microstimulationDuring the experimental protocol (up to 3 hours)Participants will indicate the anatomical location of each evoked sensation on a standardized hand map. Responses will be summarized as frequencies and percentages for each anatomical region.
Tactile discrimination performanceDuring the experimental session (up to 3 hours)Discrimination performance will be assessed using a two-alternative forced-choice (2AFC) psychophysical paradigm during intraneural microstimulation. Performance will be quantified using the Elo rating system, a continuous score derived from pairwise stimulus comparisons. The Elo rating has no predefined minimum or maximum value. Higher Elo scores indicate greater discrimination performance.

Secondary

MeasureTime frameDescription
Event-related potential amplitude during intraneural microstimulationDuring the experimental protocol (up to 3 hours)Event-related potentials (ERPs) elicited by intraneural microstimulation and recorded using 128-channel EEG will be quantified by peak amplitude (µV) of stimulus-locked cortical responses.
Event-related potential latency during intraneural microstimulationDuring the experimental protocol (up to 3 hours)Event-related potentials (ERPs) elicited by intraneural microstimulation and recorded using 128-channel EEG will be quantified by peak latency (ms) of stimulus-locked cortical responses.
EEG spectral power modulation during intraneural microstimulationDuring the experimental session (up to 3 hours)Changes in EEG spectral power recorded using 128-channel EEG during intraneural microstimulation expressed as spectral power (µV²) or percentage change from baseline (%)
Decoding accuracy of tactile stimulation conditions from EEG signalsDuring the experimental session (up to 3 hours)Machine learning-based classification of tactile stimulation conditions using EEG-derived features (classification accuracy %)

Countries

Italy

Contacts

CONTACTStefano Taddei
stefano.taddei@unipi.it+39 050993699
CONTACTCalogero Maria Oddo
calogero.oddo@santannapisa.it+39 050 883111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 10, 2026